| Market Capitalization (Millions $) |
72 |
| Shares
Outstanding (Millions) |
13 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-6 |
| Cash Flow (TTM) (Millions $) |
-5 |
| Capital Exp. (TTM) (Millions $) |
0 |
Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited is a Hong Kong-based company that specializes in the research, development, and commercialization of innovative regenerative medicine products. The company was incorporated in 2013 and is privately held.
Regencell Bioscience Holdings Limited has a team of highly experienced scientists, researchers, and executives who are committed to developing breakthrough treatments for a range of conditions, such as cancer, cardiovascular disease, diabetes, and multiple sclerosis. The company's research efforts are centered around the use of stem cells and other cell-based therapies to regenerate damaged tissues and organs.
Regencell Bioscience Holdings Limited has developed several proprietary technologies, including a stem cell isolation and culture system that enables the production of large quantities of high-quality stem cells. The company also has a platform that allows for the identification of novel therapeutic targets and the development of drugs that can selectively target these targets.
Regencell Bioscience Holdings Limited's flagship product is its stem cell-based therapy for the treatment of osteoarthritis. This therapy involves the injection of autologous or allogeneic stem cells into the affected joint to stimulate the regeneration of cartilage and other tissues. The company has also developed cell-based therapies for the treatment of cardiovascular diseases, such as myocardial infarction and heart failure, as well as for the treatment of Alzheimer's disease.
Regencell Bioscience Holdings Limited has extensive collaborations with leading academic institutions and healthcare organizations to advance its research efforts. The company has also established partnerships with pharmaceutical companies for the development and commercialization of its products.
In addition to its research efforts, Regencell Bioscience Holdings Limited is committed to ensuring the safety and efficacy of its products through rigorous preclinical and clinical testing. The company adheres to the highest standards of regulatory compliance and operates in accordance with international guidelines for the development of regenerative medicine products.
Company Address: 9/F Chinachem Leighton Plaza Causeway Bay 0
Company Phone Number: 2155 0823 Stock Exchange / Ticker: NASDAQ RGC
|
